Proteoglycan-based diversification of disease outcome in...

BMC Cancer 2015 / 12 Vol. 15; Iss. 1

Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors

Farnedi, Anna, Rossi, Silvia, Bertani, Nicoletta, Gulli, Mariolina, Silini, Enrico Maria, Mucignat, Maria Teresa, Poli, Tito, Sesenna, Enrico, Lanfranco, Davide, Montebugnoli, Lucio, Leonardi, Elisa,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
15
Language:
english
Journal:
BMC Cancer
DOI:
10.1186/s12885-015-1336-4
Date:
December, 2015
File:
PDF, 1.90 MB
english, 2015
Conversion to is in progress
Conversion to is failed